Form 4: DexCom CFO Sylvain Reports PSU Vesting, Tax Withholding
Insider Transaction Report
DexCom's EVP and Chief Financial Officer, Jereme M. Sylvain, reported the vesting of performance-based restricted stock units and subsequent tax-related share withholding.
Summary
- Jereme M. Sylvain, EVP and Chief Financial Officer of DexCom Inc. (DXCM), reported transactions on January 29, 2026.
- Acquired 7,123 shares of common stock upon the vesting of performance-based restricted stock units (PSUs) granted on March 8, 2023, due to the achievement of performance conditions.
- Disposed of 2,652 shares of common stock at a price of $73.36 per share to cover tax withholding and remittance obligations related to the net settlement of the PSUs. This was not a sale by the reporting person.
- Following these transactions, Sylvain beneficially owns 123,207 shares of DexCom common stock.
- Beneficial ownership includes 83,328 unvested restricted stock units (RSUs) with various vesting schedules through March 8, 2028, and 79 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, representing a standard executive compensation vesting and tax withholding transaction, which is a routine disclosure for company insiders.
Positives
- Achievement of performance conditions for performance-based restricted stock units (PSUs) granted on March 8, 2023, leading to the vesting of 7,123 shares, indicating the company met specific performance targets.
Negatives
- No direct negatives for the company. The disposition of 2,652 shares was for tax withholding, a standard procedure for equity compensation.
Future Outlook
NA
Management Comments
- The undersigned hereby makes, constitutes and appoints each of Jereme Sylvain, Christophe Cantenot, and Stephanie Fong, and any delegee thereof, or either of them or a delegee acting singly, and with full power of substitution, re-substitution and delegation, the undersigneds true and lawful attorney in fact...
Industry Context
StockSavvy.ai notes that routine insider filings like Form 4, detailing executive compensation and tax-related transactions, are common across all industries for publicly traded companies. They provide transparency into executive stock ownership but typically do not reflect broader industry trends or competitive dynamics.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Execution of a Power of Attorney by Jereme M. Sylvain, EVP, Chief Financial Officer, appointing Jereme M. Sylvain, Christophe Cantenot, and Stephanie Fong as attorneys-in-fact to prepare, execute, submit, and file SEC forms (including Forms 3, 4, 5, 13D, 13G, and 144) and manage EDGAR account activities. | May 12, 2025 | Enhances efficiency and compliance for SEC reporting by the reporting person, ensuring timely and accurate filings. |
Related Party Transactions
- Vesting of performance-based restricted stock units (PSUs) for Jereme M. Sylvain, an executive officer, resulting in the acquisition of 7,123 shares of common stock, which constitutes executive compensation.
- Disposition of 2,652 shares to cover tax withholding obligations related to the PSU vesting, a standard process for equity compensation for an executive.
Stakeholder Impact
- Shareholders: Provides transparency regarding executive stock ownership and compensation, but the routine nature of the transaction is unlikely to have a significant direct impact.
- Employees: The vesting of PSUs reflects the company's performance and compensation structure for executives, which can indirectly influence employee morale and retention strategies.
Next Steps
- Continued vesting of 83,328 unvested restricted stock units according to their respective schedules through March 8, 2028.
Key Dates
| Date | Description |
|---|---|
| May 12, 2025 | Date Power of Attorney was executed by Jereme Sylvain. |
| March 8, 2023 | Date performance-based restricted stock units (PSUs) were granted to the Reporting Person. |
| January 29, 2026 | Date of reported transactions (acquisition of shares from PSU vesting and disposition for tax withholding). |
| March 8, 2026 | Vesting end date for 7,256 unvested restricted stock units granted on March 8, 2023. |
| March 8, 2027 | Vesting end date for 22,798 unvested restricted stock units granted on March 8, 2025, and 17,368 unvested restricted stock units granted on March 8, 2024. |
| March 8, 2028 | Vesting end date for 35,906 unvested restricted stock units granted on March 8, 2025. |
Keywords
DexCom, DXCM, Jereme Sylvain, CFO, Insider transaction, Form 4, Restricted stock units, Performance stock units, Executive compensation, Stock vesting, Tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.